Polish Lung Cancer Group - 11th Conference

November 16 - 18, 2017 


LIM Conference Center, 65/79 Al. Jerozolimskie str.

00-697 Warsaw


 

XI Annual Conference - scientific program

Polish Lung Cancer Group 

Thursday – November 16th , 2017
Instytut of Tuberculosis and Lung Diseases 26, Plocka str. 26 01-138 Warsaw

8.00 – 14.00

Thoracic Surgery Workshop – “VATS lobectomy”

- prof. T. Orlowski – operating theatre

Workshops organized by Medtronic

Thursday – November 16th , 2017

16.00 – 19.00 Workshops

LIM Conference Center 65/79, Al. Jerozolimskie str.  00-697 Warsaw

ROOM BALTYK I
"Sequential treatment” Pulmunology Workshop

„Quality and effectivenes in NSCLC EGFR mut+ diagnosis and therapy“

1. Prof. Halina Batura – „Importance of interdisciplinary approach.“
2. Prof. Rafał Krenke – „Features and limits in noninvasive lung cancer diagnosis.“
3. Prof. Renata Langfort – „Pathomorphology diagnosis importance – what one may expect.“
4. Prof. Joanna Chorostowska- Wynimko- „Molecular diagnosis – how and when , financing.“
5. Dr Grzegorz Czyzewicz- „Is sequential therapy changing prognosis in NSCLC?“

AstraZeneca patronage

ROOM BALTYK II
Diagnostic Technicians Workshop

1. Opening – S. Konicz
2. Lung Cancer – must know: prof. R.Langfort
3. Microscopic diagnostics in lung cancer
– yesterday: dr E. Kaznowska
– today: dr P. Wisniewski    
4. Clinician – Pathomorphologist – Diagnostic Technician – cooperation importance: dr J. Pankowski

16.20 – 16.40 Coffee braek
5. Diagnostic Technician role in lung cancer diagnostic process 
- histopathology: mgr K. Wiesierska 
- cytology: mgr E. Dobek
6. Additional tests in lung cancer diagnosis. Immunochemistry importance: mgr K.Więsierska 
7. Personalized diagnosis and medicine: dr A.Szpechcinski 
8. Immunotherapy in lung cancer: doc. K.Wojas-Krawczyk 

Discussion
Summary and closing

Roche Diagnostics patronage

ROOM BALTYK III
NGO’s Workshop  - Patient’s Perspectives

1. J. Milanowski: lung cancer - diagnosis
2. R. Ramlau: lung cancer – treatment
3. T. Orlowski – Lung Cancer Registry
4. D. Zawisza (Toronto): Canadian good nursing practices
5. R. Pancewicz: mobile application for LC patients’ and relatives
6. LC patients’ NGO: Szczecin – A. Zylowska i Gdansk – E. Szmytke
7. NGO’s: ALIVIA, Rak’n’Roll, Polish Amazonki Social Movement
8. M. Cedzynska: tobacco dependencie
9. M. Manczuk: alternative methods

ROOM CHOPIN
Pathomorphology Workshop – expert’s consultation

1. „Present microscopic criteria in thymoma classification. “ - prof. Alexander Marx, dr Malgorzata Szolkowska

2. „Thymoma controversial cases - microscopic outlook consultation. “ Prof. Alexander Marx

Kawasaka patronage

ROOM WISLA

Thoracic Surgery-Pulmunology-Medical Oncology interactive workshop

“Case evaluation according to TNM 8th edition.”
prof. Tadeusz Orlowski 








Akademia Siemens Healthineers ROOM
Imaging Workshop

Prof. Edyta Szurowska
Dr Barbara Burakowska
Dr Katarzyna Dziadziuszko
Dr Malgorzata Jelitto-Gorska

Tumour in lung – CT diagnosis:

1. Characteristics of malignancy. Diagnostic trajectory. – dr Katarzyna Dziadziuszko
2. Benign characteristics – dr Barbara Burakowska
3. Hands on console:
- CAD software in lung tumour evaluation
- different lesions analysis
- non-obvious identification

Siemens patronage



Polish Thoracic Surgeons Club 


DINNER 19.00 – 21.00

Friday - November 17th , 2017

LIM Conference Center 65/79, Al. Jerozolimskie str.  00-697 Warsaw

Posters presentation in Congress Hall – whole day

9.15 „Jokohama Susi”

9.30 – 10.45  
ROOM BALTYK I+II
Plenarny Session I
„Do test PD-L1 expression ?” - MSD patronage
Chair: prof. D.Kowalski , prof. R.Ramlau

1. Is PD-L1 expression a valuable biomarker in NSCLC ? – prof. P. Krawczyk (20 min.)

2. How, when and who test PD-L1 expression? – prof. Renata Langfort (20 min.)

3. Anti-PD1/anti-PDL1 inhibitors in NSCLC – dr A. Pluzanski (20 min.)

Discussion 15 min.

10.45 „Jokohama Sushi”

Coffee break 10.45 – 11.15
Meet posters’ authors

11.15 – 12.15
ROOM   BALTYK I

PFIZER satellite session „NSCLC ALK+ patients‘ treatment in Poland – practicioners view“

1. Prof. Pawel Krawczyk „Tissue management vs molecular tests results. “ (20 min.)
2. Prof. Rafal Dziadziuszko „Practical NSCLC ALK+ treatment in Poland – chances and challenges. “ (10 min.) 
3. Prof. Dariusz Kowalski „How crizotinib has changed NSCLC ALK+ treatment in Poland.“ (20 min.)

Discussion(10 min.)

11.15 – 12.45
ROOM  BALTYK II
Plenarny Session II „Lung cancer 3 levels prevention” - PtChP patronage
Chair:prof. J.Milanowski , prof. H.Gabryel-Batura

1. Prof. J.Milanowski „Smoking and other factors in lung cancer. Tobacco cessasion.“
2. Doc. M. Adamek „Lung cancer Screening – CT, small tumors, matt glass. “
3. Prof. R. Suwinski, Prof. T. Orlowski „SBRT or surgery in early lung cancer “
4. Prof. P. Krawczyk „Advanced lung cancer – treatment algorithm. “

11.15 – 12.45
ROOM BALTYK III

Pathomorphology session 
Chair: prof. Renata Langfort,  dr Malgorzata Szolkowska

1. Lung Cancer microscopic diagnosis – medical oncologist’s expectations:  dr Pawel Badurak (20 min)
2. More expected but less tissue – standard formulation in advanced NSCLC – discussion panel. Moderator: prof. Renata Langfort (25 min)
3. Pathomorphology in dusk? Replacement by new techniques?:prof. Joanna Chorostowska-Wynimko (20 min)
4. „New precision and simple system for histological dissection" – A.Olejnik (15 min)
5. „New quality in colourig of H & E" – S.Konicz (10 min)

12.15 – 12.45

IGNYTA satellite session “New molecular targets in NSCLC”

1.Prof. Rafał Dziadziuszko “Biology and clinical significance of NTRK and ROS1 rearrangements in lung cancer” (15 min.)

2.Prof. Rodryg Ramlau “STARTRK-2 clinical trial in Poland and rest of world” (15 min.)


LUNCH  12.45 – 13.45

QIAGEN satellite session

“Diagnostics based on DNA and RNA analysis in personalized medicine”

13.45 – 16.00 
ROOM BALTYK I+II
Best of WCLC „What we may meet in 2030“– IASLC patronage
Chair: prof. M. Krzakowski, prof. T. Orlowski 

1. Prof. Rafał Dziadziuszko (Gdansk) – „Radiation oncology and immunotherapy synergistic effect”

2. Prof. Alexander Marx (Manheim) – „Biomarkers for targeted therapy in thymic epithelial tumors – state of the art”

3. Dr Natasha Leighl (Toronto) – „Immunotherapy in lung cancer”

4. Prof. Robert Pirker (Vienna) – „Systemic treatment in lung cancer”

5. Dr Allison Deal (N. Carolina) – „Symptom monitoring with patient-reported outcomes”

6. Dianne Zawisza (Toronto) – „Nursing in lung cancer”

7. Dr Lars Ek (Lund) – „Electromagnetic Navigate Bronchoscopy: Expanding Option in Lung Care”

Coffee break   16.00 – 16.30 
Meet posters’ authors

16.30 – 17.45 
ROOM BALTYK I+II
Plenary session III „EGFR and ALK inhibitors – dilemmas” - PTOK patronage
Chair: prof. P. Krawczyk, prof. M.Krzakowski

1. Systemic treatment availabe in Poland vis a vis EU and International guidelines – prof. M. Krzakowski (20 min.)
2. Available ALK rearrangement testing – prof. R. Langfort (10 min.)
3.Optimal sequence of anti-EGFR therapy – 3rd generation before 1st and 2nd generation („pro” – prof. D. Kowalski, „contra” – prof. R Ramlau) (20 min.)
4. Optimal sequence of anti-ALK therapy– 2nd generation before 1st generation („pro” – prof. R. Dziadziuszko, „contra” – dr K. Stencel) (20 min.)

Discussion 5 min.

16.30 – 17.45 
ROOM BALTYK III
Pathomorphology session B
Chair: prof. Wieslawa Grajkowska, dr Ewa Kaznowska

1. “Radiology in thoracic oncology. Brief knowledge compendium.” 
Dr Barbara Burakowska
2. „Navigating the PD-L1 testing landscape, a pharmDx solution for immunotherapy”- Eric Norbart
(15 min.)
3. Diagnostic pitfalls in thoracic oncology:
I. AIS, MIA or invasive ADC?:
dr Małgorzata Szolkowska (20 min.)
II
. Mesythelioma – recative proliferation or metastasis?: 
prof Renata Langfort (20 min.)

17.45 – 18.30
SALA BAŁTYK I +II
Bristol-Myers Squibb sponsored satellite session„Immunotherapy in sqamous NSCLC in clinical practice.”
Chair: prof. r. Ramlau

1. Immunotherapy in sqamous NSCLC –  prof. Dariusz M. Kowalski (15 min.)
2. Immunotherapy patients’ managemnt and monitoring  -  Dr Adam Pluzanski (15 min.)
3. Polish clinical practice cases presentation – Dr Maciej Bryl (15 min.)

DINNER 19.00 – 21.00

Saturday – November 18th , 2017

9.00 - 12.00 Workshops

LIM Conference Center 65/79, Al. Jerozolimskie str.  00-697 Warsaw

ROOM WISŁA
Radiation Oncology Workshop

- Prof. R. Dziadziuszko
- Dr K. Konopa

Varian patronage

ROOM NYSA
Radiation Oncology Workshop

- Prof. R. Dziadziuszko
- Dr K. Konopa

Elekta patronage

8.30 – 9.30
ROOM BALTYK I +II
Plenary session IV Inter-university cooperation: Poznań<->Białystok MOBIT
Chair: prof. J.Niklinski, prof. R.Ramlau

1. MOBIT Project (Molecular Biomarkers for Individualized Therapy): oncological biobank and integrated omic analysis - Jacek Niklinski 20 min.

2. MOBIT Project (Molecular Biomarkers for Individualized Therapy): PET/MRI integrated diagnostics- Dorota Jurgilewicz- 10 min

3. MOBIT Decision Support System - Miroslaw Kwasniewski (10min)

4. Experience with MOBIT project in Thoracic Surgery Clinic – Medical University of Poznan - Cezary Piwkowski (10 min)

5. Discussion (10 min)

8.30 – 9.30
ROOM BALTYK III
Pathomorphology – post-workshop discussin.
Chair: prof. Renata Langfort, dr Malgorzata Szolkowska


9.30 – 10.00
ROOM BALTYK I+II

3 awarded posters presentation

Chair: prof. R. Ramlau, prof. T. Orłowski

Novartis patronage

10.00 – 11.00
ROOM BALTYK I +II
AstraZeneca sattelite session „Liquiud biopsy-James Bond in the probe”

1.„Liquid biposy enigma. Quantum of solace for clinicians.” – prof. J. Chorostowska-Wynimko
2.„Licence to diagnose? Liquid biopsy exploitation.” – dr M. Bryl

Coffee break  11.00 – 11.30

11.30 – 12.15
ROOM BALTYK I +II
Plenary session V „Modern treatment and its adverse events”
Chair: prof. D.Kowalski, prof. W. Dyszkiewicz

1. Adverse events during anti-EGFR and anti-ALK therapy– dr M. Knetki-Wroblewska (20 min.)

2. Adverse events in immunotherapy – dr Dr A. Płużański (20 min.)

Discussion (5 min.) 

11.30 – 12.15
ROOM BALTYK III
Pathomorphology – post-workshop discussion.

Chair: prof. Renata Langfort, dr Malgorzata Szołkowska

12.15 - 13.15
ROOM BALTYK I +II
Plenary session VI „Mesythelioma and metastasis in lung”
Chair: prof. R.Ramlau, prof. W. Rzyman

1. Mesythelioma – state of the art – dr Daria  Swiniuch (15 min.)

2. Antiangiogenic therapy i immunotherapy in mesythelioma – prof. M. Krzakowski (20 min.)

3. Nd-YAG laser  in management of metastasis in lung  – prof. W. Dyszkiewicz (20 min.)

Discussion (5 min.)

13.15 - 13.30

Closing remarks

Polska Grupa Raka Płuca

ul. Płocka 26, 01-138 Warszawa